Colocboost
Colocboost has been studied in 1 paper since 2025: none in people yet. No study of it in people or animals has been published yet. The newest paper, May 6, 2025: “Integrative multi-omics QTL colocalization maps regulatory architecture in aging human brain”.
1 paper studies it1 findingUpdated
- In silico1
What did studies of Colocboost find?
1Studies of Colocboost measured 1 outcome; the most studied are Alzheimer's disease susceptibility loci detection (1 study).
Alzheimer's disease susceptibility loci detection
upin silico1
1 study
Alzheimer's disease susceptibility loci detection
upin silico1
Colocboost increases Alzheimer's disease susceptibility loci detection in silico (up to 2.5-fold more loci, twice the heritability).
“When colocalized against Alzheimer's disease (AD) GWAS, ColocBoost identified up to 2.5-fold more distinct colocalized loci, explaining twice the AD disease heritability”
In silicobrain cortex
Integrative multi-omics QTL colocalization maps regulatory architecture in aging human brain
medRxiv : the preprint server for health sciencesPreprint